TY - JOUR
T1 - Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events
T2 - Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study
AU - CRIC Study Investigators
AU - Cohen, Jordana B.
AU - Yang, Wei
AU - Li, Liang
AU - Zhang, Xiaoming
AU - Zheng, Zihe
AU - Orlandi, Paula
AU - Bansal, Nisha
AU - Deo, Rajat
AU - Lash, James P.
AU - Rahman, Mahboob
AU - He, Jiang
AU - Shafi, Tariq
AU - Chen, Jing
AU - Cohen, Debbie L.
AU - Matsushita, Kunihiro
AU - Shlipak, Michael G.
AU - Wolf, Myles
AU - Go, Alan S.
AU - Feldman, Harold I.
AU - Appel, Lawrence J.
AU - Nelson, Robert G.
AU - Rao, Panduranga S.
AU - Shah, Vallabh O.
AU - Townsend, Raymond R.
AU - Unruh, Mark L.
N1 - Publisher Copyright:
© 2021 National Kidney Foundation, Inc.
PY - 2022/1
Y1 - 2022/1
N2 - Rationale & Objective: Evaluating repeated measures of estimated glomerular filtration rate (eGFR) and urinary protein-creatinine ratio (UPCR) over time may enhance our ability to understand the association between changes in kidney parameters and cardiovascular disease risk. Study Design: Prospective cohort study. Setting & Participants: Annual visit data from 2,438 participants in the Chronic Renal Insufficiency Cohort (CRIC). Exposures: Average and slope of eGFR and UPCR in time-updated, 1-year exposure windows. Outcomes: Incident heart failure, atherosclerotic cardiovascular disease events, death, and a composite of incident heart failure, atherosclerotic cardiovascular disease events, and death. Analytical Approach: A landmark analysis, a dynamic approach to survival modeling that leverages longitudinal, iterative profiles of laboratory and clinical information to assess the time-updated 3-year risk of adverse cardiovascular outcomes. Results: Adjusting for baseline and time-updated covariates, every standard deviation lower mean eGFR (19 mL/min/1.73 m2) and declining slope of eGFR (8 mL/min/1.73 m2 per year) were independently associated with higher risks of heart failure (hazard ratios [HRs] of 1.82 [95% CI, 1.39-2.44] and 1.28 [95% CI, 1.12-1.45], respectively) and the composite outcome (HRs of 1.32 [95% CI, 1.11-1.54] and 1.11 [95% CI, 1.03-1.20], respectively). Every standard deviation higher mean UPCR (136 mg/g) and increasing UPCR (240 mg/g per year) were also independently associated with higher risks of heart failure (HRs of 1.58 [95% CI, 1.28-1.97] and 1.20 [95% CI, 1.10-1.29], respectively) and the composite outcome (HRs of 1.33 [95% CI, 1.17-1.50] and 1.12 [95% CI, 1.06-1.18], respectively). Limitations: Limited generalizability of annual eGFR and UPCR assessments; several biomarkers for cardiovascular disease risk were not available annually. Conclusions: Using the landmark approach to account for time-updated patterns of kidney function, average and slope of eGFR and proteinuria were independently associated with 3-year cardiovascular risk. Short-term changes in kidney function provide information about cardiovascular risk incremental to level of kidney function, representing possible opportunities for more effective management of patients with chronic kidney disease.
AB - Rationale & Objective: Evaluating repeated measures of estimated glomerular filtration rate (eGFR) and urinary protein-creatinine ratio (UPCR) over time may enhance our ability to understand the association between changes in kidney parameters and cardiovascular disease risk. Study Design: Prospective cohort study. Setting & Participants: Annual visit data from 2,438 participants in the Chronic Renal Insufficiency Cohort (CRIC). Exposures: Average and slope of eGFR and UPCR in time-updated, 1-year exposure windows. Outcomes: Incident heart failure, atherosclerotic cardiovascular disease events, death, and a composite of incident heart failure, atherosclerotic cardiovascular disease events, and death. Analytical Approach: A landmark analysis, a dynamic approach to survival modeling that leverages longitudinal, iterative profiles of laboratory and clinical information to assess the time-updated 3-year risk of adverse cardiovascular outcomes. Results: Adjusting for baseline and time-updated covariates, every standard deviation lower mean eGFR (19 mL/min/1.73 m2) and declining slope of eGFR (8 mL/min/1.73 m2 per year) were independently associated with higher risks of heart failure (hazard ratios [HRs] of 1.82 [95% CI, 1.39-2.44] and 1.28 [95% CI, 1.12-1.45], respectively) and the composite outcome (HRs of 1.32 [95% CI, 1.11-1.54] and 1.11 [95% CI, 1.03-1.20], respectively). Every standard deviation higher mean UPCR (136 mg/g) and increasing UPCR (240 mg/g per year) were also independently associated with higher risks of heart failure (HRs of 1.58 [95% CI, 1.28-1.97] and 1.20 [95% CI, 1.10-1.29], respectively) and the composite outcome (HRs of 1.33 [95% CI, 1.17-1.50] and 1.12 [95% CI, 1.06-1.18], respectively). Limitations: Limited generalizability of annual eGFR and UPCR assessments; several biomarkers for cardiovascular disease risk were not available annually. Conclusions: Using the landmark approach to account for time-updated patterns of kidney function, average and slope of eGFR and proteinuria were independently associated with 3-year cardiovascular risk. Short-term changes in kidney function provide information about cardiovascular risk incremental to level of kidney function, representing possible opportunities for more effective management of patients with chronic kidney disease.
KW - Chronic kidney disease (CKD)
KW - cardiovascular disease (CVD)
KW - cardiovascular risk
KW - eGFR slope
KW - eGFR trajectory
KW - estimated glomerular filtration rate (eGFR)
KW - heart disease
KW - heart failure
KW - landmark analysis
KW - longitudinal kidney function
KW - mortality
KW - proteinuria
KW - renal function
KW - time-updated analysis
KW - urinary protein-creatinine ratio (UPCR)
UR - http://www.scopus.com/inward/record.url?scp=85111498525&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111498525&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2021.03.021
DO - 10.1053/j.ajkd.2021.03.021
M3 - Article
C2 - 34052355
AN - SCOPUS:85111498525
SN - 0272-6386
VL - 79
SP - 36-44.e1
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 1
ER -